GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's other long-term liabilities for the quarter that ended in Mar. 2015 was $5.57 Mil.
Synageva BioPharma Corp's quarterly other long-term liabilities increased from Sep. 2014 ($5.46 Mil) to Dec. 2014 ($5.72 Mil) but then declined from Dec. 2014 ($5.72 Mil) to Mar. 2015 ($5.57 Mil).
Synageva BioPharma Corp's annual other long-term liabilities increased from Dec. 2012 ($0.00 Mil) to Dec. 2013 ($3.83 Mil) and increased from Dec. 2013 ($3.83 Mil) to Dec. 2014 ($5.72 Mil).
Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Marts balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Synageva BioPharma Corp Annual Data
|Other Long-Term Liab.||27.69||28.22||18.79||18.35||18.67||95.59||-0.00||0.00||3.83||5.72|
Synageva BioPharma Corp Quarterly Data
|Other Long-Term Liab.||0.00||0.00||0.72||1.57||3.83||4.83||5.35||5.46||5.72||5.57|